SCHEMBL10104420

SCHEMBL10104420

Cc1cc(CN2CCCC2)cc(C(F)(F)F)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
KDM4E B2RXH2 3/20 0.58
GAA P10253 1/20 0.58
CASP1 P29466 1/20 0.51
CASP5 P51878 1/20 0.51
CYP2D6 P10635 6/20 0.49
CYP3A4 P08684 5/20 0.49
CYP2C19 P33261 3/20 0.48
USP2 O75604 3/20 0.48
CYP1A2 P05177 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
TP53 P04637 1/20 0.48
TSHR P16473 4/20 0.46
CYP2C9 P11712 2/20 0.46
CHKA P35790 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13960087 0.98 ALDH1A1 (0.60) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL24565989 0.97 ALDH1A1 (0.54) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL6028265 0.88 ALDH1A1 (0.67) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL12426565 0.87 ALDH1A1 (0.51) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL428016 0.87 CHKA (0.52) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL31010361 0.86 ALDH1A1 (0.70) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL17320452 0.86 CYP2D6 (0.59) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL21951132 0.86 HIF1A (0.56) ALDH1A1KDM4EGAACASP1CASP5
SCHEMBL10104477 0.83 HRH3 (0.53) ALDH1A1KDM4EGAACYP3A4CYP1A2
SCHEMBL8974017 0.82 ALDH1A1 (0.60) ALDH1A1KDM4EGAACASP1CASP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217967-A1 INDOLINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-07-04 US disclosed
WO-2020079652-A1 KINASE INHIBITORS Insilico Medicine Hong Kong Limited (CN) 2020-04-23 WO disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
WO-2009003998-A2 ANTIPROLIFERATIVE COMPOUNDS BASED ON 5-MEMBERED HETEROCYCLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 ALDH1A1 175/4885KDM4E 2715/4885GAA 716/4885
US-20240217967-A1 INDOLINE DERIVATIVES AS DDRS INHIBITORS DDR1, DDR2, DDRGK1 ALDH1A1 3751/4885KDM4E 2592/4885GAA 3688/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 ALDH1A1 860/4885KDM4E 1224/4885GAA 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.